GF:FRE Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.
This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol FSNUF.
This company has ADRs that trade in the U.S. as the symbol FSNUY.This company has cross-listed shares that trade in the U.S. as the symbol FSNUF.
24.18 EUR
As of 03/23/2023
Security Information
Category1: Global Equity
Category2: Common stocks
Category3: Developed markets ex-US
GICS sector: Health Care
Industry:
Index country: Germany
Country of incorporation: Germany
IPO date: 12/04/1997
Stock exchange: Frankfurt Stock Exchange
Exchange country: Germany
Market cap: 0 EUR
Current dividend yield: 0.00%
Sedol: 4352097